Paola D. Marcato

Cp
Ribeirao Preto, SP 14040903, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Peptide-mediated immunomodulation of tumor microenvironment in triple-negative breast cancer: A comprehensive review.

Peptide-mediated immunomodulation of tumor microenvironment in triple-negative breast cancer: A comprehensive review.

Journal: The Journal of pharmacology and experimental therapeutics

Published: December 02, 2025

THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancer.

THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancer.

Journal: Biomarker research

Published: July 18, 2025

Selective inhibition of ALDH1A3 impedes breast cancer growth and metastasis by blocking ALDH1A3-driven transcriptional programs.

Selective inhibition of ALDH1A3 impedes breast cancer growth and metastasis by blocking ALDH1A3-driven transcriptional programs.

Journal: iScience

Published: May 31, 2025

Expression of carcinoma ecotypes in the tumor microenvironment predicts response to neoadjuvant therapy in early-stage breast cancer.

Expression of carcinoma ecotypes in the tumor microenvironment predicts response to neoadjuvant therapy in early-stage breast cancer.

Journal: Scientific reports

Published: May 20, 2025

LncRNA NRAD1 regulates the triple-negative breast cancer transcriptome by miRNA biogenesis, localization, and predominately non-ceRNA interactions.

LncRNA NRAD1 regulates the triple-negative breast cancer transcriptome by miRNA biogenesis, localization, and predominately non-ceRNA interactions.

Journal: Scientific reports

Published: May 01, 2025

LINC01929 mediates breast cancer immunosuppression and is an immunotherapy target.

LINC01929 mediates breast cancer immunosuppression and is an immunotherapy target.

Journal: iScience

Published: March 12, 2025

Editorial Expression of Concern: The NAD+ salvage pathway modulates cancer cell viability via p73.

Editorial Expression of Concern: The NAD+ salvage pathway modulates cancer cell viability via p73.

Journal: Cell death and differentiation

Published: October 18, 2024

ALDH1A3 is the switch that determines the balance of ALDH+ and CD24-CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer.

ALDH1A3 is the switch that determines the balance of ALDH+ and CD24-CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer.

Journal: Oncogene

Published: May 02, 2024

Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways.

Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways.

Journal: International journal of molecular sciences

Published: February 28, 2024

Phloridzin Docosahexaenoate, an Omega-3 Fatty Acid Ester of a Flavonoid Precursor, Inhibits Angiogenesis by Suppressing Endothelial Cell Proliferation, Migration, and Differentiation.

Phloridzin Docosahexaenoate, an Omega-3 Fatty Acid Ester of a Flavonoid Precursor, Inhibits Angiogenesis by Suppressing Endothelial Cell Proliferation, Migration, and Differentiation.

Journal: Biomolecules

Published: September 22, 2023

LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer.

LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer.

Journal: Gene

Published: September 17, 2023

ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathway.

ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathway.

Journal: Molecular oncology

Published: April 20, 2023

Showing 1-12 of 59

Last Updated: 09/26/2026